» Articles » PMID: 38558906

Association Between High-sensitivity Cardiac Troponin T Levels and Incident Stroke in the Elderly Japanese Population: Results from the Tohoku Medical Megabank Community-based Cohort Study

Abstract

Elevated levels of circulating high-sensitivity cardiac troponin T (hs-cTnT) are associated with cardiovascular disease. This study aimed to examine whether hs-cTnT levels are associated with incident stroke in the elderly population. The Iwate Tohoku Medical Megabank Organization pooled participant data for a community-based cohort study (n = 15,063, 69.6 ± 3.4 years), with a mean follow-up period of 5.23 years for all-cause death and incident stroke. The follow-up revealed 316 incident strokes, including atherothrombotic (n = 98), cardioembolic (n = 54), lacunar (n = 63), hemorrhagic (n = 101), and 178 all-cause deaths. Participants were classified into quartiles according to hs-cTnT levels (Q1 ≦ 4 ng/L, Q2: 5-6 ng/L, Q3: 7-9 ng/L, and Q4 > 9 ng/L). After adjusting for sex, age, smoking, drinking, systolic blood pressure, estimated glomerular filtration rate, N-terminal pro-brain natriuretic peptide, hemoglobin A1c, and lipid profile, a Cox proportional hazard model showed that higher hs-cTnT levels were associated with ischemic stroke (Q1 vs. Q4, hazard ratio [HR] = 2.24, 95 % confidence interval [CI] = 1.12-4.51, p = 0.023). The incident of total stroke was not associated with hs-cTnT levels (Q1 vs. Q4, HR 1.39, 95 % CI = 0.89-1.74, p = 0.145). Numerical differences were highest regarding incident lacunar stroke subtypes; however, this association was not statistically significant. Higher hs-cTnT concentrations were associated with ischemic stroke in the elderly Japanese population.

Citing Articles

Association of Troponin T measurements with long-term outcomes in patients with coronary artery disease participating in a secondary prevention trial.

Kaldal A, Tonstad S, Jortveit J BMC Cardiovasc Disord. 2023; 23(1):210.

PMID: 37118703 PMC: 10142253. DOI: 10.1186/s12872-023-03249-0.

References
1.
Giannitsis E, Kurz K, Hallermayer K, Jarausch J, Jaffe A, Katus H . Analytical validation of a high-sensitivity cardiac troponin T assay. Clin Chem. 2009; 56(2):254-61. DOI: 10.1373/clinchem.2009.132654. View

2.
Camen S, Palosaari T, Reinikainen J, Sprunker N, Niiranen T, Gianfagna F . Cardiac Troponin I and Incident Stroke in European Cohorts: Insights From the BiomarCaRE Project. Stroke. 2020; 51(9):2770-2777. PMC: 7447179. DOI: 10.1161/STROKEAHA.120.029452. View

3.
Grodin J, Neale S, Wu Y, Hazen S, Tang W . Prognostic comparison of different sensitivity cardiac troponin assays in stable heart failure. Am J Med. 2014; 128(3):276-82. PMC: 4340722. DOI: 10.1016/j.amjmed.2014.09.029. View

4.
Caprio F, Sorond F . Cerebrovascular Disease: Primary and Secondary Stroke Prevention. Med Clin North Am. 2019; 103(2):295-308. DOI: 10.1016/j.mcna.2018.10.001. View

5.
Lindahl B, Venge P, Wallentin L . Relation between troponin T and the risk of subsequent cardiac events in unstable coronary artery disease. The FRISC study group. Circulation. 1996; 93(9):1651-7. DOI: 10.1161/01.cir.93.9.1651. View